Pharmacogenetic implementation for CYP2C19 and pharmacokinetics of voriconazole in children with malignancy or inborn errors of immunity.

Autor: Shoji K; Division of Infectious Diseases, Department of Medical Subspecialties, National Center for Child Health and Development, Tokyo, Japan. Electronic address: shoji-k@ncchd.go.jp., Hikino K; Laboratory for Pharmacogenomics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan., Saito J; Department of Pharmacy, National Center for Child Health and Development, Tokyo, Japan., Matsui T; Division of Infectious Diseases, Department of Medical Subspecialties, National Center for Child Health and Development, Tokyo, Japan; Children's Cancer Center, National Center for Child Health and Development, Tokyo, Japan., Utano T; Department of Pharmacy, National Center for Child Health and Development, Tokyo, Japan., Takebayashi A; Children's Cancer Center, National Center for Child Health and Development, Tokyo, Japan., Tomizawa D; Children's Cancer Center, National Center for Child Health and Development, Tokyo, Japan., Kato M; Children's Cancer Center, National Center for Child Health and Development, Tokyo, Japan., Matsumoto K; Children's Cancer Center, National Center for Child Health and Development, Tokyo, Japan., Ishikawa T; Division of Immunology, National Center for Child Health and Development, Tokyo, Japan., Kawai T; Division of Immunology, National Center for Child Health and Development, Tokyo, Japan., Nakamura H; Department of Research and Development Supervision, National Center for Child Health and Development, Tokyo, Japan., Miyairi I; Division of Infectious Diseases, Department of Medical Subspecialties, National Center for Child Health and Development, Tokyo, Japan; Department of Microbiology, Immunology and Biochemistry, University of Tennessee Health Science Center, Memphis, TN, USA; Department of Pediatrics, Hamamatsu University School of Medicine, Shizuoka, Japan., Terao C; RIKEN Center for Integrative Medical Sciences, Yokohama, Japan; Clinical Research Center, Shizuoka General Hospital, Shizuoka, Japan; The School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan., Mushiroda T; Laboratory for Pharmacogenomics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.

Publikováno v: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy [J Infect Chemother] 2024 Dec; Vol. 30 (12), pp. 1280-1288. Date of Electronic Publication: 2024 Jun 17.

Current Status and Issues of Collaboration Between Physicians and Pharmacists in Fertility Preservation.

Autor: Maezawa T; Department of Obstetrics and Gynecology, Graduate School of Medicine, Mie University, Tsu, Japan., Yonemura M; Department of Pharmacy, National Cancer Center Hospital East, Kashiwa, Japan., Baba K; Department of Pharmacy, National Cancer Center Hospital East, Kashiwa, Japan., Takeuchi H; Department of Obstetrics and Gynecology, Graduate School of Medicine, Mie University, Tsu, Japan., Hioki M; Department of Pharmacy, Shiga University of Medical Science, Otsu, Japan., Nishimura A; Department of Pharmacy, Hokkaido University Hospital, Kita-Ku, Japan., Minatogawa H; Department of Pharmacy, St. Marianna University School of Medicine, Kawasaki, Japan., Utano T; Department of Pharmacy, National Center for Child Health and Development, Setagaya-ku, Japan., Amino K; Department of Pharmacy, Japanese Red Cross Suwa Hospital, Suwa, Japan., Ito M; Department of Obstetrics and Gynecology, Faculty of Medicine, University of Toyama, Toyama, Japan., Akita N; Department of Pediatrics, Japanese Red Cross Aichi Medical Center Nagoya Daiichi Hospital, Nakamura-ku, Japan., Iwatani T; Department of Breast and Endocrine Surgery, Okayama University Hospital, Kita-ku, Japan., Suzuki N; Department of Obstetrics and Gynecology, St. Marianna University School of Medicine, Kawasaki, Japan.

Publikováno v: Journal of adolescent and young adult oncology [J Adolesc Young Adult Oncol] 2024 Jun; Vol. 13 (3), pp. 514-522. Date of Electronic Publication: 2024 Apr 03.

Low NUDT15 expression levels due to biallelic NUDT15 variants and 6-mercaptopurine intolerance.

Autor: Yoshida M; Department of Pediatric Hematology and Oncology Research, Research Institute, National Center for Child Health and Development, Tokyo, Japan., Brown SA; Department of Immunology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA., Moriyama T; Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA., Nishii R; Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA., Tsujimoto SI; Department of Pediatric Hematology and Oncology Research, Research Institute, National Center for Child Health and Development, Tokyo, Japan., Yamada Y; Children's Cancer Center, National Center for Child Health and Development, Tokyo, Japan., Yoshida K; Department of Pediatric Hematology and Oncology Research, Research Institute, National Center for Child Health and Development, Tokyo, Japan., Shirai R; Department of Pediatric Hematology and Oncology Research, Research Institute, National Center for Child Health and Development, Tokyo, Japan., Osumi T; Department of Pediatric Hematology and Oncology Research, Research Institute, National Center for Child Health and Development, Tokyo, Japan.; Children's Cancer Center, National Center for Child Health and Development, Tokyo, Japan., Utano T; Department of Pharmaceuticals, National Center for Child Health and Development, Tokyo, Japan., Fukano R; Department of Pediatrics, Yamaguchi University Graduate School of Medicine, Ube, Japan., Kudo K; Department of Pediatrics, Hirosaki University Graduate School of Medicine, Hirosaki, Japan., Sakaguchi K; Department of Pediatrics, Hamamatsu University School of Medicine, Hamamatsu, Japan., Arakawa Y; Department of Hematology/Oncology, Saitama Children's Medical Center, Saitama, Japan., Koh K; Department of Hematology/Oncology, Saitama Children's Medical Center, Saitama, Japan., Sekiguchi M; Department of Pediatrics, Graduate School of Medicine, the University of Tokyo, Tokyo, Japan., Sekimizu M; Department of Pediatrics, National Hospital Organization Nagoya Medical Center, Nagoya, Japan., Miyamura T; Department of Pediatrics, Osaka University Graduate School of Medicine, Suita, Japan., Ishida H; Department of Pediatrics, Okayama University Hospital, Okayama, Japan., Inukai T; Department of Pediatrics, School of Medicine, University of Yamanashi, Yamanashi, Japan., Tomizawa D; Children's Cancer Center, National Center for Child Health and Development, Tokyo, Japan., Kiyokawa N; Department of Pediatric Hematology and Oncology Research, Research Institute, National Center for Child Health and Development, Tokyo, Japan., Kato M; Department of Pediatric Hematology and Oncology Research, Research Institute, National Center for Child Health and Development, Tokyo, Japan.; Children's Cancer Center, National Center for Child Health and Development, Tokyo, Japan.; Department of Pediatrics, Graduate School of Medicine, the University of Tokyo, Tokyo, Japan., Yang JJ; Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.; Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.

Publikováno v: British journal of haematology [Br J Haematol] 2022 Oct; Vol. 199 (2), pp. 270-276. Date of Electronic Publication: 2022 Jul 29.

Comparison of clonazepam and levetiracetam in children for prevention of busulfan-induced seizure in hematopoietic stem cell transplantation.

Autor: Tsujimoto SI; Children's Cancer Center, National Center for Child Health and Development, Tokyo, Japan., Shirai R; Children's Cancer Center, National Center for Child Health and Development, Tokyo, Japan., Utano T; Department of Pharmaceuticals, National Center for Child Health and Development, Tokyo, Japan., Osumi T; Children's Cancer Center, National Center for Child Health and Development, Tokyo, Japan., Matsumoto K; Department of Clinical Pharmaceutics, Faculty of Pharmaceutical Sciences, Doshisha Women's College of Liberal Arts, Kyoto, Japan., Shioda Y; Children's Cancer Center, National Center for Child Health and Development, Tokyo, Japan., Kiyotani C; Children's Cancer Center, National Center for Child Health and Development, Tokyo, Japan., Uchiyama T; Children's Cancer Center, National Center for Child Health and Development, Tokyo, Japan., Deguchi T; Children's Cancer Center, National Center for Child Health and Development, Tokyo, Japan., Terashima K; Children's Cancer Center, National Center for Child Health and Development, Tokyo, Japan., Tomizawa D; Children's Cancer Center, National Center for Child Health and Development, Tokyo, Japan., Matsumoto K; Children's Cancer Center, National Center for Child Health and Development, Tokyo, Japan., Kato M; Children's Cancer Center, National Center for Child Health and Development, Tokyo, Japan. katom-tky@umin.ac.jp.

Publikováno v: International journal of hematology [Int J Hematol] 2020 Mar; Vol. 111 (3), pp. 463-466. Date of Electronic Publication: 2019 Dec 20.

A system design for TDMA mobile radios.

Autor: Nakajima, N., Kuramoto, M., Kinoshita, K., Utano, T.

Publikováno v: 40th IEEE Conference on Vehicular Technology; 1990, p295-298, 4p